INCSTAR announces the launch of its second generation Parathyroid Hormone-related Protein (PTHrP) assay.STILLWATER, Minn.--(BUSINESS WIRE)--Aug. 31, 1995--INCSTAR Corporation (ASE (Adaptive Server Enterprise) A relational DBMS from Sybase that runs on Windows NT/2000, Linux and a variety of Unix platforms. ASE is a comprehensive and robust data management product with a long history dating back to the late 1980s. :ISR) announced today that it is launching worldwide its second generation Parathyroid Hormone-related Protein Parathyroid hormone-related protein (or PTHrP) is a protein occasionally secreted by cancer cells (breast cancer, certain types of lung cancer including squamous cell carcinoma). However, it also has normal functions. (PTHrP) assay. PTHrP is the agent responsible for the condition of humoral hu·mor·al adj. 1. Relating to body fluids, especially serum. 2. Relating to or arising from any of the bodily humors. Humoral Pertaining to or derived from a body fluid. hypercalcemia of malignancy hypercalcemia of malignancy A clinical complex, 50% of which results from hypersecretion of parathyroid hormone-related protein–PTHRP, aka parathyroid hormone-related peptide; HCM may result from either direct replacement–eg, in lympho- and (HHM). This is a condition in which serum calcium is increased to potentially life threatening levels. This second generation assay is in a testing format known as immunoradiometric (IRMA An earlier trade name for a variety of host connectivity hardware and software products originally developed by Digital Communications Associates (DCA) and later acquired by Attachmate Corporation. Irma was not an acronym, rather it was the lady's name. ) and is an upgrade to the company's existing PTHrP radioimmunoassay (RIA (Rich Internet Application) A Web-based application that approaches the speed and elegance of a local application. An RIA may refer to a browser-based application that uses AJAX or another enhanced coding technique. ) assay. This assay will provide customers with a superior product that has significantly improved sensitivity and better definition of the protein under investigation. This product will be distributed as a "research use only" product in the US and is targeted to the clinical research market. Internationally, the company will pursue registration in several European countries as well as Japan. INCSTAR is a medical immunodiagnostics company focused on the development, production and worldwide marketing of reagents, particularly for bone/mineral metabolism, endocrinology, infectious and autoimmune diseases. INCSTAR markets its products globally, through its direct sales force in North America and internationally, through its affiliated company, Sorin Biomedica, S.p.A., and independent distributors. Sorin Biomedica, S.p.A., which holds 52% of INCSTAR's shares, is a medical technology company with businesses focused on the diagnostic, cardiovascular and hemodialysis segments of the international healthcare market, and had worldwide sales last year of $800 million. INCSTAR had sales last year of $43 million. CONTACT: INCSTAR Corp. Tom Maun, 612/439-9710 or Dewe Rogerson Kate De Santis, 212/688-6840 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion